Correlation Between Li Kang and Univacco Technology

Can any of the company-specific risk be diversified away by investing in both Li Kang and Univacco Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Li Kang and Univacco Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Li Kang Biomedical and Univacco Technology, you can compare the effects of market volatilities on Li Kang and Univacco Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Li Kang with a short position of Univacco Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Li Kang and Univacco Technology.

Diversification Opportunities for Li Kang and Univacco Technology

0.76

Correlation Coefficient

Li Kang  Univacco Technology

Poor diversification

The 3 months correlation between 6242 and Univacco is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Li Kang Biomedical and Univacco Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Univacco Technology and Li Kang is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Li Kang Biomedical are associated (or correlated) with Univacco Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Univacco Technology has no effect on the direction of Li Kang i.e., Li Kang and Univacco Technology go up and down completely randomly.

Pair Corralation between Li Kang and Univacco Technology

Assuming the 90 days trading horizon Li Kang Biomedical is expected to generate 0.83 times more return on investment than Univacco Technology. However, Li Kang Biomedical is 1.21 times less risky than Univacco Technology. It trades about 0.05 of its potential returns per unit of risk. Univacco Technology is currently generating about 0.04 per unit of risk. If you would invest  4,285  in Li Kang Biomedical on December 23, 2024 and sell it today you would earn a total of  175.00  from holding Li Kang Biomedical or generate 4.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Li Kang Biomedical  vs.  Univacco Technology

Li Kang Biomedical

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Li Kang Biomedical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Li Kang is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Univacco Technology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Univacco Technology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Univacco Technology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Li Kang and Univacco Technology

The main advantage of trading using opposite Li Kang and Univacco Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Li Kang position performs unexpectedly, Univacco Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Univacco Technology will offset losses from the drop in Univacco Technology's long position.

The idea behind Li Kang Biomedical and Univacco Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.